Immunovia announces updated financial calendar

Rhea-AI Summary

• English
• French
• German
• Italian
• Korean
• Spanish

Immunovia, a diagnostics company focused on increasing pancreatic cancer survival rates through early detection, announces an updated financial calendar for 2024. The company plans to publish its Annual Report on April 29, 2024, followed by the Q1 Report on the same day. Immunovia's mission is to develop blood-based tests for detecting proteins and antibodies associated with pancreatic cancer.

LUND, Sweden, April 22, 2024 /PRNewswire/ -- Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, updates its financial calendar for 2024.

Annual Report to be published	April 29, 2024
Q1 Report, 2024	April 29, 2024
Annual General Meeting	June 4, 2024
Q2 Report, 2024	August 22, 2024
Q3 Report, 2024	November 14, 2024

 

For more information, please contact:

Karin Almqvist Liwendahl
Chief Financial Officer
karin.almqvist.liwendahl@immunovia.com
+46 709 11 56 08

Immunovia in brief 

Immunovia AB is a diagnostic company whose mission is to increase survival rates for patients with pancreatic cancer through early detection. Immunovia is focused on the development and commercialization of simple blood-based testing to detect proteins and antibodies that indicate a high-risk individual has developed pancreatic cancer.

Immunovia collaborates and engages with healthcare providers, leading experts and patient advocacy groups to make its test available to individuals at increased risk for pancreatic cancer. 

USA is the world's largest market for detection of pancreatic cancer. The company estimates that in the USA, 1.8 million individuals are at high-risk for pancreatic cancer and could benefit from annual surveillance testing.

Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm. For more information, please visit www.immunovia.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/immunovia-ab/r/immunovia-announces-updated-financial-calendar,c3965327

 

View original content:https://www.prnewswire.com/news-releases/immunovia-announces-updated-financial-calendar-302123329.html

SOURCE Immunovia AB

FAQ

When will Immunovia publish its Annual Report for 2024?

Immunovia will publish its Annual Report for 2024 on April 29, 2024.

What is the date of Immunovia's Q1 Report for 2024?

The Q1 Report for 2024 will also be published on April 29, 2024.

What is the date of Immunovia's Annual General Meeting in 2024?

Immunovia's Annual General Meeting for 2024 is scheduled for June 4, 2024.

Where are Immunovia's shares listed?

Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm.

What is Immunovia's mission?

Immunovia's mission is to increase survival rates for patients with pancreatic cancer through early detection.